Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score > 2): a retrospective cohort study.
Dominique BertrandMarie MatignonAntoine MorelLebourg LudivineMathilde LemoineMélanie HanoyFrank Le RoyDorian NezamMouad HamzaouiTristan de NattesAnissa MoktefiArnaud FrançoisCharlotte LaurentIsabelle EtienneDominique GuerrotPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
The replacement of CNI with belatacept in patients with decreased allograft function and vascular lesions is associated with an improvement in graft survival, and represents a valuable option in a context of organ shortage. Caution should be made about the increased risk of opportunistic infection.
Keyphrases